Re-evaluation of cefepime or piperacillin-tazobactam to decrease use of carbapenems in extended-spectrum beta-lactamase-producing Enterobacterales bloodstream infections (REDUCE-BSI)

• Principais autores: Catherine H. Vu (Autor), Veena Venugopalan (Autor), Barbara A. Santevecchi (Autor), Stacy A. Voils (Autor), Reuben Ramphal (Autor), Kartikeya Cherabuddi (Autor), Kathryn DeSear (Autor)
• Formato: Livro
• Publicado em: Cambridge University Press, 2022-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Objective: To re-examine the use of noncarbapenems (NCBPs), specifically piperacillin-tazobactam (PTZ) and cefepime (FEP), for extended-spectrum beta-lactamase-producing Enterobacterales bloodstream infections (ESBL-E BSIs). Design: Retrospective cohort study. Setting: Tertiary-care, academ...